tiprankstipranks
Advertisement
Advertisement

DRUG Stock Latest News

Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
The FlyPsychedelic: Enveric, NRx, Bright Minds report quarterly earnings
22h ago
CMND
CMPS
Bright Minds Biosciences Boosts Cash Reserves as R&D Losses Widen in Q2 2026 Filing
PremiumCompany Announcements
Bright Minds Biosciences Boosts Cash Reserves as R&D Losses Widen in Q2 2026 Filing
2d ago
6K
DRUG
Bright Minds price target raised to $220 from $190 at Piper Sandler
PremiumThe Fly
Bright Minds price target raised to $220 from $190 at Piper Sandler
2d ago
DRUG
Is DRUG a Buy, Before Earnings?
PremiumPre-Earnings
Is DRUG a Buy, Before Earnings?
10d ago
DRUG
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
PremiumThe Fly
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
1M ago
BMY
CMND
Bright Minds initiated with a Buy at Jefferies
PremiumThe FlyBright Minds initiated with a Buy at Jefferies
1M ago
DRUG
Buy Rating on BMB-101 Driven by Strong Phase 2 Epilepsy Data, Differentiated Safety, and Prader–Willi Upside Supporting DCF Valuation
Premium
Ratings
Buy Rating on BMB-101 Driven by Strong Phase 2 Epilepsy Data, Differentiated Safety, and Prader–Willi Upside Supporting DCF Valuation
2M ago
DRUG
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
Premium
The Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
3M ago
PBM
ATAI
Bright Minds price target raised to $145 from $115 at H.C. Wainwright
PremiumThe Fly
Bright Minds price target raised to $145 from $115 at H.C. Wainwright
3M ago
DRUG
Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
PremiumRatings
Compelling Phase 2 Data and Prader–Willi Upside Support Buy Rating and Favorable Risk/Reward for DRUG
3M ago
DRUG
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
PremiumRatings
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise
3M ago
DRUG
Bright Minds price target lowered to $126 from $142 at Baird
PremiumThe Fly
Bright Minds price target lowered to $126 from $142 at Baird
3M ago
DRUG
Bright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
PremiumCompany AnnouncementsBright Minds Biosciences Files Q1 FY2026 Financials Showing Strong Cash, Higher R&D Loss
3M ago
6K
DRUG
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
Premium
Company Announcements
Bright Minds Biosciences Raises US$175 Million in Share Offering to Advance CNS Drug Pipeline
4M ago
6K
DRUG
Bright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
Premium
Company Announcements
Bright Minds Biosciences Launches $175 Million Share Offering to Fund Neurology Drug Pipeline
4M ago
6K
DRUG
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
PremiumThe Fly
Psychedelic: Bright Minds reports results from Phase 2 BMB-101 trial
4M ago
CMPS
DRUG
Bright Minds 1.945M share Secondary priced at $90.00
PremiumThe Fly
Bright Minds 1.945M share Secondary priced at $90.00
4M ago
DRUG
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
PremiumCompany Announcements
Bright Minds Biosciences Prices Upsized US$175 Million Public Offering and Ends ATM Program
4M ago
6K
DRUG
Bright Minds Biosciences Ends Equity Distribution Deal With Piper Sandler and Cantor
PremiumCompany Announcements
Bright Minds Biosciences Ends Equity Distribution Deal With Piper Sandler and Cantor
4M ago
6K
DRUG
Bright Minds price target raised to $142 from $82 at Baird
PremiumThe FlyBright Minds price target raised to $142 from $82 at Baird
5M ago
DRUG
Bright Minds price target raised to $147 from $72 at BTIG
Premium
The Fly
Bright Minds price target raised to $147 from $72 at BTIG
5M ago
DRUG
Bright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline
Premium
Company Announcements
Bright Minds Biosciences Launches US$100 Million Public Offering to Fund CNS Drug Pipeline
5M ago
6K
DRUG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >